Polycystic kidney disease can be autosomal dominant or recessive. Autosomal dominant PKD is caused by mutations that result in multiple bilateral cysts in the kidneys and liver, and those with a parent with the disease have a 50% chance of developing it. Diagnosis involves family history, imaging showing cysts, and ultrasound or MRI. There is no treatment to prevent cyst growth, but blood pressure and infections should be controlled. Autosomal recessive PKD requires both parents to have the disease, and is diagnosed through ultrasound showing large cystic kidneys and liver fibrosis. Treatment focuses on intensive care, dialysis, and transplantation as survival into adulthood is now possible.
Autosomal Recessive Polycystic Kidney Disease (ARPKD) is caused by mutations in the PKHD1 gene and results in cyst formation in the kidneys and congenital hepatic fibrosis. It occurs in about 1 in 20,000 live births. The condition is characterized by rapid enlargement of the kidneys in infants due to cysts in the collecting ducts. This can lead to complications like congestive heart failure. While some infants may die shortly after birth, those who survive can have improved outcomes with 5-year survival rates around 85%. Treatment focuses on management of symptoms like hypertension and electrolyte imbalances.
This document discusses polycystic kidney disease (PKD), specifically autosomal dominant polycystic kidney disease (ADPKD). It defines ADPKD as a genetic disorder caused by mutations in PKD1 and PKD2 genes, characterized by multiple bilateral renal cysts and cysts in other organs. Symptoms may include abdominal or flank pain, hematuria, hypertension, enlarged kidneys with nodular surfaces, and liver cysts. Diagnosis involves family history, clinical examination, and ultrasound evaluation of the kidneys. While there is no specific treatment, management focuses on blood pressure control, treating infections, reducing pain, and renal replacement therapies like dialysis or transplantation for end-stage renal disease.
This document discusses polycystic kidney disease (PKD), a genetic disorder where cysts form on the kidneys. There are two types - autosomal dominant PKD, which usually develops later in life and is more common, and autosomal recessive PKD, which develops in childhood. Symptoms include abdominal pain and tenderness, blood in the urine, and high blood pressure. The condition is diagnosed using scans to detect cysts on the kidneys. Treatment focuses on managing symptoms through medication and potentially surgery if cysts become problematic.
Polycystic disease of the kidney (PKD) is a disorder in which major portion of the renal parenchyma is converted into cysts of varying size .
Fluid-filled cysts distributed over the kidney results in massive enlargement of the kidneys.
This document provides an overview of polycystic kidney disease (PKD), including a history, introduction to the different types (autosomal dominant and recessive), pathophysiology, diagnostic tests and treatments. It discusses the first known case in the 16th century Polish king and subsequent studies defining it as a clinical entity. The two main types are described in more detail, focusing on genetics, characteristics and management. A case study is presented of a 42-year old female diagnosed with autosomal dominant PKD who underwent genetic testing identifying a heterozygous nonsense mutation.
Autosomal recessive polycystic kidney disease (ARPKD) is a rare genetic disorder characterized by progressive kidney enlargement and varying degrees of liver abnormalities. It is caused by mutations in the PKHD1 gene and results in abnormalities in the kidney and liver collecting ducts. Clinically, ARPKD presents in early childhood with flank masses, hypertension, urinary concentration defects, and can lead to renal insufficiency. On pathology, the kidneys appear sponge-like with multiple small cysts radiating from the medulla to cortex. There is no known family history of the disease as it is transmitted through an autosomal recessive trait.
1. Autosomal dominant polycystic kidney disease (ADPKD) is a genetic disorder characterized by multiple bilateral renal cysts and cysts in other organs caused by mutations in PKD1 and PKD2 genes.
2. The renal cysts enlarge over time, ultimately leading to renal failure in half of patients by age 60.
3. Treatment focuses on controlling blood pressure, treating infections, reducing pain, and delaying renal failure through medications such as ACE inhibitors or ARBs.
A 78-year-old patient presented with a history of hypertension and renal failure. Ultrasound showed enlarged kidneys with multiple cysts in both kidneys. The patient was diagnosed with autosomal dominant polycystic kidney disease (ADPKD), a genetic disorder characterized by growth of numerous cysts in both kidneys that can lead to kidney failure. ADPKD is caused by mutations in genes PKD1 or PKD2 and symptoms include back pain, headaches, and kidney cysts that worsen over time, eventually causing renal failure in around 50% of patients by age 60 if left untreated.
Cystic kidney diseases in children can be genetic or non-genetic in origin. Genetic causes include autosomal recessive polycystic kidney disease (ARPKD), autosomal dominant polycystic kidney disease (ADPKD), juvenile nephronophthisis, and glomerulocystic kidney disease. Non-genetic causes include simple cysts, multicystic dysplastic kidney, acquired cysts, and caliceal cysts. Ultrasound is the primary imaging modality used for diagnosis. ARPKD is the most severe genetic cause, occurring in 1 in 50,000, and is characterized by cystic dilatation of the collecting tubules affecting both kidneys
This document discusses polycystic kidney disease (PKD). It describes PKD as a common hereditary disease characterized by the development of multiple renal cysts. There are two forms: autosomal recessive PKD which is fatal in infancy, and autosomal dominant PKD which is more common and can lead to end stage renal disease in around 50% of cases by age 60. The document provides details on the clinical features, investigations, and management of autosomal dominant PKD.
This document describes the case of a 3-year-old boy who presented with abnormal movements and fever. He was found to have chronic renal failure, hypocalcemia, hypomagnesaemia, and hypertensive encephalopathy. Imaging showed enlarged kidneys consistent with autosomal dominant polycystic kidney disease (ADPKD). He was treated for his hypertension and renal failure. Hypertensive encephalopathy is characterized by neurological symptoms due to a rapid rise in blood pressure and failure of the brain's autoregulation. It is commonly seen in patients with renal disease and is managed by slowly lowering the blood pressure over 24-48 hours.
Adult polycystic kidney disease (ADPKD) is a genetic disorder characterized by the growth of numerous cysts in the kidneys and other organs. It is caused by mutations in one of two genes, PKD1 or PKD2, and affects around 1 in 1000 people. Symptoms include back or abdominal pain, hematuria, and hypertension. Extrarenal manifestations include cysts in the liver and pancreas as well as cerebral and coronary artery aneurysms. Diagnosis is made based on imaging and family history. While there is no cure, treatment focuses on slowing disease progression, managing complications like hypertension, and renal replacement therapy for end-stage renal disease.
The document discusses polycystic kidney disease (PKD), which is an inherited disorder characterized by the growth of numerous cysts in the kidneys. There are three main types of PKD - autosomal dominant PKD, autosomal recessive PKD, and acquired cystic kidney disease. Autosomal dominant PKD is the most common, accounting for 90% of cases and caused by mutations in the PKD1 or PKD2 genes. Autosomal recessive PKD is rare and caused by mutations in the PKHD1 gene. Symptoms can range from high blood pressure to kidney failure. Treatments aim to control complications through medication and dialysis, with kidney transplantation as an option.
Multicystic dysplastic kidney (MCDK) is a congenital abnormality characterized by multiple cysts replacing renal parenchyma. It results from ureteric bud obstruction during fetal development. Unilateral MCDK is usually asymptomatic and detected incidentally, while bilateral MCDK is fatal due to end-stage renal disease. Diagnosis is made using ultrasound and DMSA renal scan showing nonfunctional cystic kidneys. Treatment involves monitoring unilateral cases and supportive care for bilateral cases.
There are many different types of kidney cysts that can be classified in various ways. An ideal classification system would take into account morphological features, pathogenesis, and therapeutic potential. Autosomal dominant polycystic kidney disease (ADPKD) is the most common cystic kidney disease and is characterized by multiple bilateral cysts of varying sizes in the kidneys and liver. It has a prevalence of 1 in 400 to 1,000 people and is caused by mutations in the PKD1 or PKD2 genes.
Autosomal dominant polycystic kidney disease (ADPKD) is a genetic disorder characterized by multiple bilateral renal cysts that can lead to kidney failure, with mutations in two genes causing cyst formation through disordered polycystin function; it commonly causes hypertension, pain, infection, and kidney failure and can involve the liver and other organs; management focuses on slowing progression through blood pressure control, pain management, and potentially targeting the renin-angiotensin system or mTOR pathway.
- Autosomal dominant polycystic kidney disease (ADPKD) is characterized by multiple bilateral renal cysts that lead to kidney enlargement and failure. It has a prevalence of 1 in 400 to 1000 live births.
- The disease is caused by mutations in the PKD1 and PKD2 genes which code for polycystin proteins 1 and 2. These proteins are involved in cellular signaling pathways regulating cell proliferation and adhesion. Loss of function of these proteins results in focal cyst formation in the kidneys.
- Current treatments aim to slow cyst growth and decline in kidney function. Vasopressin receptor antagonists like tolvaptan have shown some efficacy in reducing total kidney volume increase in
This document discusses cystic diseases of the kidney. It describes different types of kidney cysts including polycystic kidney disease. Autosomal dominant polycystic kidney disease is the most common type and is caused by mutations in the PKD1 or PKD2 genes. It is characterized by bilateral enlargement of the kidneys due to multiple fluid-filled cysts. Symptoms may include pain, hematuria, and signs of chronic kidney disease. The document also discusses other cystic conditions like autosomal recessive polycystic kidney disease, medullary cystic kidney disease, and multicyctic renal dysplasia.
This document presents a case report of a newborn with multicystic dysplastic kidney (MCDK). The key points are:
1) Prenatal ultrasound identified a cystic enlargement of the left kidney in the fetus.
2) After a preterm delivery, examination of the newborn found generalized edema, dysmorphic features, and a grossly edematous left MCDK.
3) Workup revealed renal failure. Imaging showed a small right kidney. The newborn was treated with peritoneal dialysis.
Urinary tract infections are caused by bacteria like E. coli entering the urinary tract. Women are more prone to UTIs, which can affect the urethra, bladder, ureters or kidneys. Common symptoms include urgency, frequent urination and abdominal or back pain. Diagnosis involves testing a urine sample for bacteria and white blood cells. Left untreated, UTIs during pregnancy can travel to the kidneys due to hormonal changes. Proper treatment uses antibiotics to resolve the infection.
The document discusses various pediatric renal cystic diseases including their definitions, categories, genetics, presentations, associations, and management. Multicystic dysplastic kidney is defined as involving the entire kidney with primitive ducts and cysts present from early development. It is the renal cystic condition that arises prior to nephron formation.
This document discusses various renal cystic diseases and conditions. It covers cortical and medullary cysts, polycystic kidney disease, multicystic renal dysplasia and extra-parenchymal cysts. Autosomal dominant polycystic kidney disease is described as the most common hereditary cystic renal disease affecting 1 in 1000 people typically in the third decade of life. Imaging findings for simple cysts, polycystic kidney disease, multicystic renal dysplasia and extrarenal cysts on ultrasound, intravenous urography, CT and MRI are summarized.
This document lists various poisons, their fatal doses, and estimated fatal periods. It includes common acids, bases, salts, metals, organic compounds, plants, and venoms. Ranging from as little as 5 mg to over 10 grams, fatal doses are provided for substances like sulfuric acid, nitric acid, hydrochloric acid, oxalic acid, phenol, potassium hydroxide, sodium carbonate, formaldehyde, iodine, bromide, phosphorus, antimony, ricin, abrus, ergot, opium, morphine, alcohol, barbiturates, chloral hydrate, pesticides, DDT, cannabis, cocaine, strychnine, hydrogen cyanide
Ballint syndrome : Q world Neurology Notes by Tanmay mehtaDr. Akruti Mehta
Ìý
Ballint syndrome : Q world Neurology Notes by Tanmay mehta for PG medical Entrace exams like AIPGMEE , AIIMS , DNB , PGI and USMLE
Facebook.com/qworld.co.in
Autosomal recessive polycystic kidney disease (ARPKD) is a rare genetic disorder characterized by progressive kidney enlargement and varying degrees of liver abnormalities. It is caused by mutations in the PKHD1 gene and results in abnormalities in the kidney and liver collecting ducts. Clinically, ARPKD presents in early childhood with flank masses, hypertension, urinary concentration defects, and can lead to renal insufficiency. On pathology, the kidneys appear sponge-like with multiple small cysts radiating from the medulla to cortex. There is no known family history of the disease as it is transmitted through an autosomal recessive trait.
1. Autosomal dominant polycystic kidney disease (ADPKD) is a genetic disorder characterized by multiple bilateral renal cysts and cysts in other organs caused by mutations in PKD1 and PKD2 genes.
2. The renal cysts enlarge over time, ultimately leading to renal failure in half of patients by age 60.
3. Treatment focuses on controlling blood pressure, treating infections, reducing pain, and delaying renal failure through medications such as ACE inhibitors or ARBs.
A 78-year-old patient presented with a history of hypertension and renal failure. Ultrasound showed enlarged kidneys with multiple cysts in both kidneys. The patient was diagnosed with autosomal dominant polycystic kidney disease (ADPKD), a genetic disorder characterized by growth of numerous cysts in both kidneys that can lead to kidney failure. ADPKD is caused by mutations in genes PKD1 or PKD2 and symptoms include back pain, headaches, and kidney cysts that worsen over time, eventually causing renal failure in around 50% of patients by age 60 if left untreated.
Cystic kidney diseases in children can be genetic or non-genetic in origin. Genetic causes include autosomal recessive polycystic kidney disease (ARPKD), autosomal dominant polycystic kidney disease (ADPKD), juvenile nephronophthisis, and glomerulocystic kidney disease. Non-genetic causes include simple cysts, multicystic dysplastic kidney, acquired cysts, and caliceal cysts. Ultrasound is the primary imaging modality used for diagnosis. ARPKD is the most severe genetic cause, occurring in 1 in 50,000, and is characterized by cystic dilatation of the collecting tubules affecting both kidneys
This document discusses polycystic kidney disease (PKD). It describes PKD as a common hereditary disease characterized by the development of multiple renal cysts. There are two forms: autosomal recessive PKD which is fatal in infancy, and autosomal dominant PKD which is more common and can lead to end stage renal disease in around 50% of cases by age 60. The document provides details on the clinical features, investigations, and management of autosomal dominant PKD.
This document describes the case of a 3-year-old boy who presented with abnormal movements and fever. He was found to have chronic renal failure, hypocalcemia, hypomagnesaemia, and hypertensive encephalopathy. Imaging showed enlarged kidneys consistent with autosomal dominant polycystic kidney disease (ADPKD). He was treated for his hypertension and renal failure. Hypertensive encephalopathy is characterized by neurological symptoms due to a rapid rise in blood pressure and failure of the brain's autoregulation. It is commonly seen in patients with renal disease and is managed by slowly lowering the blood pressure over 24-48 hours.
Adult polycystic kidney disease (ADPKD) is a genetic disorder characterized by the growth of numerous cysts in the kidneys and other organs. It is caused by mutations in one of two genes, PKD1 or PKD2, and affects around 1 in 1000 people. Symptoms include back or abdominal pain, hematuria, and hypertension. Extrarenal manifestations include cysts in the liver and pancreas as well as cerebral and coronary artery aneurysms. Diagnosis is made based on imaging and family history. While there is no cure, treatment focuses on slowing disease progression, managing complications like hypertension, and renal replacement therapy for end-stage renal disease.
The document discusses polycystic kidney disease (PKD), which is an inherited disorder characterized by the growth of numerous cysts in the kidneys. There are three main types of PKD - autosomal dominant PKD, autosomal recessive PKD, and acquired cystic kidney disease. Autosomal dominant PKD is the most common, accounting for 90% of cases and caused by mutations in the PKD1 or PKD2 genes. Autosomal recessive PKD is rare and caused by mutations in the PKHD1 gene. Symptoms can range from high blood pressure to kidney failure. Treatments aim to control complications through medication and dialysis, with kidney transplantation as an option.
Multicystic dysplastic kidney (MCDK) is a congenital abnormality characterized by multiple cysts replacing renal parenchyma. It results from ureteric bud obstruction during fetal development. Unilateral MCDK is usually asymptomatic and detected incidentally, while bilateral MCDK is fatal due to end-stage renal disease. Diagnosis is made using ultrasound and DMSA renal scan showing nonfunctional cystic kidneys. Treatment involves monitoring unilateral cases and supportive care for bilateral cases.
There are many different types of kidney cysts that can be classified in various ways. An ideal classification system would take into account morphological features, pathogenesis, and therapeutic potential. Autosomal dominant polycystic kidney disease (ADPKD) is the most common cystic kidney disease and is characterized by multiple bilateral cysts of varying sizes in the kidneys and liver. It has a prevalence of 1 in 400 to 1,000 people and is caused by mutations in the PKD1 or PKD2 genes.
Autosomal dominant polycystic kidney disease (ADPKD) is a genetic disorder characterized by multiple bilateral renal cysts that can lead to kidney failure, with mutations in two genes causing cyst formation through disordered polycystin function; it commonly causes hypertension, pain, infection, and kidney failure and can involve the liver and other organs; management focuses on slowing progression through blood pressure control, pain management, and potentially targeting the renin-angiotensin system or mTOR pathway.
- Autosomal dominant polycystic kidney disease (ADPKD) is characterized by multiple bilateral renal cysts that lead to kidney enlargement and failure. It has a prevalence of 1 in 400 to 1000 live births.
- The disease is caused by mutations in the PKD1 and PKD2 genes which code for polycystin proteins 1 and 2. These proteins are involved in cellular signaling pathways regulating cell proliferation and adhesion. Loss of function of these proteins results in focal cyst formation in the kidneys.
- Current treatments aim to slow cyst growth and decline in kidney function. Vasopressin receptor antagonists like tolvaptan have shown some efficacy in reducing total kidney volume increase in
This document discusses cystic diseases of the kidney. It describes different types of kidney cysts including polycystic kidney disease. Autosomal dominant polycystic kidney disease is the most common type and is caused by mutations in the PKD1 or PKD2 genes. It is characterized by bilateral enlargement of the kidneys due to multiple fluid-filled cysts. Symptoms may include pain, hematuria, and signs of chronic kidney disease. The document also discusses other cystic conditions like autosomal recessive polycystic kidney disease, medullary cystic kidney disease, and multicyctic renal dysplasia.
This document presents a case report of a newborn with multicystic dysplastic kidney (MCDK). The key points are:
1) Prenatal ultrasound identified a cystic enlargement of the left kidney in the fetus.
2) After a preterm delivery, examination of the newborn found generalized edema, dysmorphic features, and a grossly edematous left MCDK.
3) Workup revealed renal failure. Imaging showed a small right kidney. The newborn was treated with peritoneal dialysis.
Urinary tract infections are caused by bacteria like E. coli entering the urinary tract. Women are more prone to UTIs, which can affect the urethra, bladder, ureters or kidneys. Common symptoms include urgency, frequent urination and abdominal or back pain. Diagnosis involves testing a urine sample for bacteria and white blood cells. Left untreated, UTIs during pregnancy can travel to the kidneys due to hormonal changes. Proper treatment uses antibiotics to resolve the infection.
The document discusses various pediatric renal cystic diseases including their definitions, categories, genetics, presentations, associations, and management. Multicystic dysplastic kidney is defined as involving the entire kidney with primitive ducts and cysts present from early development. It is the renal cystic condition that arises prior to nephron formation.
This document discusses various renal cystic diseases and conditions. It covers cortical and medullary cysts, polycystic kidney disease, multicystic renal dysplasia and extra-parenchymal cysts. Autosomal dominant polycystic kidney disease is described as the most common hereditary cystic renal disease affecting 1 in 1000 people typically in the third decade of life. Imaging findings for simple cysts, polycystic kidney disease, multicystic renal dysplasia and extrarenal cysts on ultrasound, intravenous urography, CT and MRI are summarized.
This document lists various poisons, their fatal doses, and estimated fatal periods. It includes common acids, bases, salts, metals, organic compounds, plants, and venoms. Ranging from as little as 5 mg to over 10 grams, fatal doses are provided for substances like sulfuric acid, nitric acid, hydrochloric acid, oxalic acid, phenol, potassium hydroxide, sodium carbonate, formaldehyde, iodine, bromide, phosphorus, antimony, ricin, abrus, ergot, opium, morphine, alcohol, barbiturates, chloral hydrate, pesticides, DDT, cannabis, cocaine, strychnine, hydrogen cyanide
Ballint syndrome : Q world Neurology Notes by Tanmay mehtaDr. Akruti Mehta
Ìý
Ballint syndrome : Q world Neurology Notes by Tanmay mehta for PG medical Entrace exams like AIPGMEE , AIIMS , DNB , PGI and USMLE
Facebook.com/qworld.co.in
Dr. Bhatia's Medical Institute (DBMI) is India's first coaching centre which helps PG Entrance Exam aspirants realise their dreams of having a successful and flourishing career in Medicine. DBMI is not only the most experienced institute among its competitors but it also boasts a team of leading educationists and a panel of experienced doctors to guide the students.
Chapter 4 - Cardiology - Dr. Bhatia's Medical Coaching InstituteDr. Bhatia's
Ìý
Dr. Bhatia's provides students with the best infrastructure and advanced study material which help them outshine their competitors. As a result, over the last 10 years, DBMI students have emerged toppers in all the major exams (AIIMS, NEET, DNB etc).Dr. Bhatia's Medical Institute is without doubt the best bet for those preparing for PGEE.
Endocrinology - Dr. Bhatia's Medical Coaching InstituteDr. Bhatia's
Ìý
Dr. Bhatia's Medical Institute (DBMI) is India's first coaching centre which helps PG Entrance Exam aspirants realise their dreams of having a successful and flourishing career in Medicine. DBMI is not only the most experienced institute among its competitors but it also boasts a team of leading educationists and a panel of experienced doctors to guide the students.
Chronic Obstructive Pulmonary Disease (COPD) is a preventable and treatable disease characterized by airflow limitation that is usually progressive and associated with an abnormal inflammatory response in the lungs. The diagnosis of COPD requires two spirometric measures: FEV1 and its ratio to FVC (FEV1/FVC), which must be less than 0.7. Treatment involves smoking cessation, vaccinations, bronchodilators, corticosteroids, pulmonary rehabilitation, and oxygen therapy or lung transplantation for advanced cases.
This document summarizes information about appendiceal adenocarcinoma. It discusses how the majority of patients present with acute appendicitis and describes the intestinal and mucinous tumor types. It also covers tumor classification, including mucinous tumors of uncertain malignant potential. Prognosis depends on factors like histologic type, T stage, and tumor grade. Treatment recommendations include simple appendectomy for early stage disease and hemicolectomy for more advanced tumors. Adjuvant chemotherapy and intraperitoneal hyperthermic chemotherapy are discussed as additional treatment options. Cytoreductive surgery can help palliate patients with peritoneal carcinomatosis.
Acquired hemophilia A is a rare bleeding disorder caused by autoantibodies against factor VIII. It most commonly presents in older patients as severe bleeding and has a high mortality rate if not properly treated. Evaluation involves testing for prolonged aPTT and ruling out an inhibitor through mixing studies. Treatment focuses on controlling bleeding with bypassing agents or factor VIII while also using immunosuppressants to eliminate the autoantibody inhibitor. Proper management can reduce bleeding and inhibitor levels, but monitoring is needed due to the slow response to therapy.
Colon cancer is the fourth most common cancer in the US. Approximately 96,830 new cases of colon cancer and 40,000 cases of rectal cancer occur each year. While incidence rates have decreased, it remains the second leading cause of cancer deaths. Approximately 20% of colon cancer cases are associated with hereditary factors like Lynch syndrome and Familial Adenomatous Polyposis. Universal genetic testing of tumors is recommended to identify hereditary cases so that at-risk family members can be identified. First line treatments for metastatic colon cancer include FOLFOX, CapeOx, and FOLFIRI combinations, often with added targeted therapies like bevacizumab, cetuximab, or panitumumab
The document summarizes evidence and guidelines for managing locally advanced rectal cancer. It discusses that neoadjuvant chemoradiation is preferred over postoperative chemoradiation based on trials showing lower local recurrence rates and less toxicity. Long-course neoadjuvant chemoradiation followed by surgery 6-8 weeks later is the standard approach. Post-treatment assessment of tumor response helps predict outcomes, with complete response indicating a good prognosis. Adjuvant chemotherapy after surgery may further improve survival based on meta-analyses of trials. Guidelines recommend a multidisciplinary, tailored approach incorporating staging, treatment response, and patient factors.
This document summarizes the results of a clinical trial investigating the efficacy and safety of pembrolizumab (anti-PD-1 antibody) in patients with advanced melanoma that progressed after treatment with ipilimumab. The overall response rate was 26% in the 2 mg/kg group and 10% in the 10 mg/kg group, with responses ongoing after 1 year. Pembrolizumab demonstrated a manageable safety profile, with grade 3-4 drug-related adverse events occurring in 12% of patients. This trial provides evidence that pembrolizumab is an effective treatment option for patients with advanced melanoma who have progressed on ipilimumab.
This document discusses anal carcinoma. It covers the overview, risk factors which include HPV and anal intercourse, and the strong association with HPV-16 and HPV-18. It also discusses risk reduction through treatment of high-grade anal intraepithelial neoplasia, a precursor to anal cancer. The anatomy of the anal region and canal is described. Sentinel nodes are the inguinal nodes. Primary treatment of non-metastatic anal cancer involves chemotherapy with radiotherapy to improve local control and reduce colostomies.
Megakaryopoiesis and thrombopoiesis involve the production of megakaryocytes and platelets from hematopoietic stem cells in the bone marrow. Megakaryoblasts are early stage megakaryocytes that are 8-24 μm in size with minimal nuclear lobulation and scant cytoplasm. They express surface adhesion molecules like integrin αIIbβ3 and glycoprotein Ib-IX complex. Megakaryoblasts undergo endomitosis, replicating their DNA without cell division to become polyploid. Cytokines such as thrombopoietin are critical for megakaryoblast survival and proliferation.
Cystic kidney diseases can be genetic or acquired. Autosomal dominant polycystic kidney disease (ADPKD) is a common genetic condition characterized by numerous fluid-filled cysts in the kidneys that worsen over time, potentially leading to kidney failure. Autosomal recessive polycystic kidney disease (ARPKD) presents in infancy with enlarged cystic kidneys and often liver disease, and can be fatal. Other cystic conditions include medullary sponge kidney cysts in the kidney papillae and nephronophthiasis-medullary cystic complex cysts at the corticomedullary junction. Simple cortical cysts are very common incidental findings. Ren
13. oldIntroduction to nephrology 1 & 2.pptYusuphShittu
Ìý
This document provides an introduction to nephrology and outlines renal embryogenesis and common renal diseases in children. It discusses the significance of Congenital Anomalies of the Kidney and Urinary Tract (CAKUT) as a leading cause of chronic kidney failure in children. It describes tests of renal function and various renal malformations including obstructive uropathies, renal cystic diseases, renal agenesis, and horseshoe kidney. Surgical treatments for conditions like posterior urethral valves and bladder exstrophy are also mentioned.
This document discusses congenital malformations of the kidneys, focusing on cystic diseases. It describes three broad groups of kidney malformations: abnormalities in renal tissue amount, anomalies of position/form/orientation, and anomalies of differentiation. It then classifies and describes cystic kidney diseases in detail. The major cystic diseases discussed are multicystic renal dysplasia, adult polycystic kidney disease (ADPKD), and infantile polycystic kidney disease (ARPKD). ADPKD is inherited dominantly and manifests in adulthood, while ARPKD is inherited recessively and presents in infancy, often leading to death from renal failure.
Polycystic kidney disease (PKD) is a genetic disorder characterized by numerous fluid-filled cysts that grow in the kidneys, destroying normal kidney tissue and leading to loss of kidney function over many years. There are two major forms: autosomal dominant PKD, which usually causes symptoms between ages 30-40 but can occur earlier, and the rare autosomal recessive form which causes symptoms from birth. As the cysts enlarge the kidneys and kidney function declines, patients may experience high blood pressure, pain, and ultimately kidney failure requiring dialysis or transplant. While there is no cure, treatment focuses on blood pressure control, pain management, and antibiotics for infections to help manage the condition.
This document discusses congenital malformations of the kidney. It is divided into three sections: abnormalities in renal tissue amount, anomalies in position and shape, and cystic diseases. Cystic diseases are further classified as multicystic renal dysplasia and polycystic kidney disease. Polycystic kidney disease occurs in two forms - an adult autosomal dominant form and a rare infantile autosomal recessive form. The adult form typically manifests between ages 30-50 with back pain, bleeding, infections and hypertension, while the infantile form causes renal failure in early childhood.
Cystic diseases of the kidney can be congenital or acquired and range from benign and asymptomatic to severe and life-threatening. There are several types of cystic kidney disease including polycystic kidney disease (PKD), which is autosomal dominant and involves multiple expanding cysts leading to kidney destruction. Multicystic dysplastic kidney disease (MCDK) is a non-functioning dysplastic kidney with multiple cysts present at birth. Acquired cystic kidney disease develops secondary to long-term dialysis and carries an increased risk of kidney tumors.
Developmental anomalies of Renal systemsudarshan731
Ìý
This document summarizes the development, anomalies, and course of the renal and urinary systems. It describes how the kidneys ascend from the pelvis to the abdomen during development. It then discusses various congenital anomalies that can affect the kidneys such as agenesis, hypoplasia, horseshoe kidney, and ectopic location. Ureteral anomalies like double ureters, megaureters, and UPJ obstruction are also covered. The course of the ureters is described, including their retroperitoneal path and three areas of constriction. Clinical correlations are provided regarding sites of obstruction and surgical considerations.
Clinical Manifestations of Autosomal Dominant Polycystic Kidney Disease.pdfJim Jacob Roy
Ìý
ADPKD is characterized by progressive formation of epithelial lined cysts in the kidney. It can affect multiple systems.
In this document , the clinical manifestations of ADPKD are described in detail.
Congenital Anomalies Of UG System PATHOLOGY.pptxirtzaali420
Ìý
Congenital anomalies of the genitourinary system can affect the urinary tract (kidneys, ureters, bladder) or genital tract. They include conditions like renal agenesis (absence of one or both kidneys), renal hypoplasia (small, underdeveloped kidneys), horseshoe kidney (kidneys fused at the base), and cystic kidney diseases. Cryptorchidism is the failure of one or both testes to descend into the scrotum. If left uncorrected, these congenital anomalies can damage the kidneys, cause infertility, or increase cancer risk.
Hypertension can be caused by underlying renal disease through several mechanisms: renal artery stenosis, chronic glomerulonephritis, chronic pyelonephritis, polycystic kidney diseases, and polyarteritis nodosa. Imaging plays a role in diagnosing renal artery stenosis and evaluating kidney size and structure in renal failure and congenital kidney anomalies. Bladder tumors are most commonly transitional cell carcinoma and are best detected by cystoscopy although other imaging modalities can provide information on tumor extent.
The document describes the sonographic appearance of the fetal kidneys, bladder, and urinary tract. It discusses how the kidneys appear hyper-echoic and oval shaped in the first trimester, becoming less echogenic over time with corticomedullary differentiation appearing at 14-15 weeks. The bladder is first seen at 9 weeks gestation and empties every 25-30 minutes in the second and third trimester. Various urinary tract abnormalities are described such as renal agenesis, ectopic or fused kidneys, renal cystic diseases, hydronephrosis, and lower urinary tract obstruction. Causes, appearances, and characteristics of different abnormalities are provided.
Our case report presents a ten-year-old boy who complains abdominal pain and rectal bleeding for more than six months. Other clinical findings were digital hippocratism and failure to thrive. Colonoscopy had shown 12 polyps from anus to cecum whose histology confirmed Juvenile character, non adenomatous and free of dysplasia. Diagnosis of Juvenile Polyposis Syndrome was more probable but a differential diagnosis from other intestinal polyposis especially from hamartomatous syndromes is crucial.
This document discusses gastroesophageal reflux disease (GERD) in children. It defines GERD and covers topics like pathophysiology, prevalence, symptoms, diagnosis, and management. Regarding pathophysiology, it describes factors like lower esophageal sphincter (LES) tone and transient LES relaxations that can allow reflux. It notes that GERD symptoms are common in children and can impact quality of life. Diagnosis involves history, physical exam, tests like pH monitoring and endoscopy. Treatment goals are to relieve symptoms, heal esophagitis, prevent complications, and maintain remission.
1. Qworld Nephrology Notes Tanmay Mehta
AUTOSOMAL RECESSIVE POLYCYSTIC KIDNEY DISEASE
ï‚· Chromosome 6 p21
ï‚· single genetic disease with variable phenotypic presentation
ï‚· neonatal, infantile, or juvenile
ï‚· relative degree of involvement of the kidneys and liver
ï‚· At birth the kidneys are enlarged with
a smooth external surface.
ï‚· The distal tubules and collecting ducts
are dilated into elongated cysts
that are arranged in a radial fashion.
ï‚· As the patient ages, the cysts may
become more spherical and the
disease can be confused with ADPKD.
ï‚· Interstitial fibrosis is also seen as renal
function deteriorates
Liver involvement includes
ï‚· proliferation and dilation of
intrahepatic bile ducts as well as
ï‚· periportal fibrosis.
ï‚· The majority of cases are diagnosed in the first yearQ of life, presenting as Qbilateral
Qabdominal masses.
ï‚· Death in the neonatal period is most commonly due to pulmonary hypoplasiaQ.
ï‚· Hypertension Qand impaired urinary concentrating abilityQ are common
ï‚· course to ESRD is variable, though many children maintain adequate kidney function for
years
ï‚· Older children present with complications secondary to congenital hepatic fibrosis
ï‚· Hepatosplenomegaly,
ï‚· portal hypertension,Q and
ï‚· esophageal varices
ï‚· QUltrasound is the most common technique used to diagnose ARPKD, prenatally and in
childhood: enlarged kidneys with increased echogenicity
ï‚· IVP : SUNBURST PATTERNQ
ï‚· Aggressive treatment of hypertension and urinary tract infection are
the major goals
ï‚· Dialysis and transplant are appropriate when kidney
failure occurs.
ï‚· Hepatic fibrosis may lead to life-threatening variceal
hemorrhage, requiring sclerotherapy or portosystemic shunts.